PMC:1064895 / 19334-19724 JSONTXT 22 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T14613 0-5 NNP denotes IL-17
T14614 6-10 NNP denotes mRNA
T14615 11-21 NN denotes expression
T14616 22-24 IN denotes in
T14617 25-27 NNP denotes RA
T14618 28-32 NNP denotes PBMC
T14619 33-35 TO denotes To
T14620 36-39 VB denotes see
T14621 40-47 IN denotes whether
T14622 48-56 JJ denotes enhanced
T14623 57-62 NN denotes IL-17
T14624 63-73 NN denotes production
T14625 74-79 MD denotes could
T14626 80-82 VB denotes be
T14627 83-92 VBN denotes regulated
T14628 93-95 IN denotes at
T14629 96-97 DT denotes a
T14630 98-113 JJ denotes transcriptional
T14631 114-119 NN denotes level
T14632 119-120 , denotes ,
T14633 121-138 JJ denotes semi-quantatitive
T14634 139-146 NN denotes reverse
T14635 147-160 NN denotes transcription
T14636 161-171 NN denotes polymerase
T14637 172-177 NN denotes chain
T14638 178-186 NN denotes reaction
T14639 187-190 VBD denotes was
T14640 191-200 VBN denotes performed
T14641 200-201 . denotes .
T14642 202-204 PRP denotes We
T14643 205-213 VBD denotes observed
T14644 214-215 DT denotes a
T14645 216-230 JJ denotes dose-dependent
T14646 231-239 NN denotes increase
T14647 240-242 IN denotes in
T14648 243-248 NNP denotes IL-17
T14649 249-253 NNP denotes mRNA
T14650 254-265 NNS denotes transcripts
T14651 266-271 IN denotes after
T14652 272-283 NN denotes stimulation
T14653 284-288 IN denotes with
T14654 289-297 JJ denotes anti-CD3
T14655 297-298 : denotes ;
T14656 299-303 DT denotes this
T14657 304-307 VBD denotes was
T14658 308-317 VBN denotes inhibited
T14659 318-320 IN denotes by
T14660 321-324 DT denotes the
T14661 325-329 NNP denotes PI3K
T14662 330-339 NN denotes inhibitor
T14663 340-348 NNP denotes LY294002
T14664 349-352 CC denotes and
T14665 353-355 IN denotes by
T14666 356-359 DT denotes the
T14667 360-365 JJ denotes NF-κB
T14668 366-375 NN denotes inhibitor
T14669 376-380 NNP denotes PDTC
T14670 381-382 -LRB- denotes (
T14671 382-386 NNP denotes Fig.
T14672 387-388 CD denotes 5
T14673 388-389 -RRB- denotes )
T14674 389-390 . denotes .
R8059 T14613 T14614 compound IL-17,mRNA
R8060 T14614 T14615 compound mRNA,expression
R8061 T14615 T14615 ROOT expression,expression
R8062 T14616 T14615 prep in,expression
R8063 T14617 T14618 compound RA,PBMC
R8064 T14618 T14616 pobj PBMC,in
R8065 T14619 T14620 aux To,see
R8066 T14620 T14615 advcl see,expression
R8067 T14621 T14627 mark whether,regulated
R8068 T14622 T14624 amod enhanced,production
R8069 T14623 T14624 compound IL-17,production
R8070 T14624 T14627 nsubjpass production,regulated
R8071 T14625 T14627 aux could,regulated
R8072 T14626 T14627 auxpass be,regulated
R8073 T14627 T14620 ccomp regulated,see
R8074 T14628 T14627 prep at,regulated
R8075 T14629 T14631 det a,level
R8076 T14630 T14631 amod transcriptional,level
R8077 T14631 T14628 pobj level,at
R8078 T14632 T14635 punct ",",transcription
R8079 T14633 T14635 amod semi-quantatitive,transcription
R8080 T14634 T14635 compound reverse,transcription
R8081 T14635 T14638 compound transcription,reaction
R8082 T14636 T14638 compound polymerase,reaction
R8083 T14637 T14638 compound chain,reaction
R8084 T14638 T14640 nsubjpass reaction,performed
R8085 T14639 T14640 auxpass was,performed
R8086 T14640 T14627 conj performed,regulated
R8087 T14641 T14615 punct .,expression
R8088 T14642 T14643 nsubj We,observed
R8089 T14643 T14643 ROOT observed,observed
R8090 T14644 T14646 det a,increase
R8091 T14645 T14646 amod dose-dependent,increase
R8092 T14646 T14643 dobj increase,observed
R8093 T14647 T14646 prep in,increase
R8094 T14648 T14649 compound IL-17,mRNA
R8095 T14649 T14650 compound mRNA,transcripts
R8096 T14650 T14647 pobj transcripts,in
R8097 T14651 T14646 prep after,increase
R8098 T14652 T14651 pobj stimulation,after
R8099 T14653 T14652 prep with,stimulation
R8100 T14654 T14653 pobj anti-CD3,with
R8101 T14655 T14658 punct ;,inhibited
R8102 T14656 T14658 nsubjpass this,inhibited
R8103 T14657 T14658 auxpass was,inhibited
R8104 T14658 T14643 ccomp inhibited,observed
R8105 T14659 T14658 agent by,inhibited
R8106 T14660 T14662 det the,inhibitor
R8107 T14661 T14662 compound PI3K,inhibitor
R8108 T14662 T14659 pobj inhibitor,by
R8109 T14663 T14662 appos LY294002,inhibitor
R8110 T14664 T14659 cc and,by
R8111 T14665 T14659 conj by,by
R8112 T14666 T14669 det the,PDTC
R8113 T14667 T14669 amod NF-κB,PDTC
R8114 T14668 T14669 compound inhibitor,PDTC
R8115 T14669 T14665 pobj PDTC,by
R8116 T14670 T14671 punct (,Fig.
R8117 T14671 T14669 appos Fig.,PDTC
R8118 T14672 T14671 nummod 5,Fig.
R8119 T14673 T14669 punct ),PDTC
R8120 T14674 T14643 punct .,observed